Nicholas Company’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.78M Buy
76,963
+40
+0.1% +$4.14K 0.14% 123
2026
Q1
$7.44M Sell
76,923
-510
-0.7% -$52.3K 0.15% 124
2025
Q4
$8.22M Sell
77,433
-7,305
-9% -$847K 0.14% 130
2025
Q3
$10.8M Sell
84,738
-40
-0% -$4.76K 0.18% 114
2025
Q2
$10.4M Hold
84,778
0.17% 118
2025
Q1
$8.59M Buy
84,778
+75
+0.1% +$7.32K 0.15% 134
2024
Q4
$7.82M Sell
84,703
-50
-0.1% -$4.91K 0.13% 151
2024
Q3
$8.19M Hold
84,753
0.13% 148
2024
Q2
$7.27M Hold
84,753
0.12% 156
2024
Q1
$7M Hold
84,753
0.12% 167
2023
Q4
$5.65M Buy
84,753
+3,475
+4% +$225K 0.1% 187
2023
Q3
$5.46M Buy
81,278
+3,150
+4% +$217K 0.11% 179
2023
Q2
$5.29M Buy
+78,128
New +$4.9M 0.1% 188

Other funds holding EHC

Nicholas Company's EHC Position: Q2 2026 in Review

Nicholas Company increased its Encompass Health (EHC) stake by 0.05% in Q2 2026, buying an estimated $4.14K and bringing the position to 76,963 shares worth $7.78M. The position accounts for 0.14% of the portfolio, ranked #123.

Nicholas Company first reported a position in EHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.8M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Nicholas Company held 76,963 shares of Encompass Health worth $7.78M as of Q2 2026.
  • Nicholas Company bought 40 Encompass Health shares in Q2 2026, an estimated $4.14K.
  • Encompass Health made up 0.14% of Nicholas Company's portfolio in Q2 2026, its #123 holding.
  • Nicholas Company first reported a position in Encompass Health in Q2 2023 and has held it in 13 quarters since.
  • Nicholas Company's Encompass Health position peaked at $10.8M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.